|
gptkbp:instance_of
|
gptkb:television_channel
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:digoxin
|
|
gptkbp:activities
|
calcium channel inhibition
|
|
gptkbp:approves
|
gptkb:legislation
gptkb:1981
gptkb:Australia
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:brand
|
gptkb:Isoptin
gptkb:Verelan
Calan
|
|
gptkbp:category
|
gptkb:C
|
|
gptkbp:clinical_trial
|
Phase IV
|
|
gptkbp:contraindication
|
cardiogenic shock
severe hypotension
sick sinus syndrome
|
|
gptkbp:developed_by
|
gptkb:Knoll_Pharmaceuticals
|
|
gptkbp:dosage_form
|
80-480 mg per day
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:formulation
|
extended-release tablet
injection solution
immediate-release tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
verapamil
|
|
gptkbp:ingredients
|
C27 H38 N2 O5
|
|
gptkbp:interacts_with
|
gptkb:beer
gptkb:digoxin
statins
beta blockers
|
|
gptkbp:is_atype_of
|
C08 D A01
|
|
gptkbp:is_available_on
|
generic drug
|
|
gptkbp:is_used_for
|
gptkb:musician
hypertension
supraventricular tachycardia
|
|
gptkbp:lifespan
|
5 to 12 hours
|
|
gptkbp:manager
|
oral
intravenous
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:side_effect
|
dizziness
fatigue
headache
nausea
rash
constipation
hypotension
bradycardia
peripheral edema
AV block
|
|
gptkbp:type_of
|
52-53-9
|